BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8524635)

  • 41. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
    Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors.
    Cela ME; Holladay MS; Rooney CM; Richardson S; Alexander B; Krance RA; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1996 Feb; 17(2):243-7. PubMed ID: 8640174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatal pneumopathy in children after bone marrow transplantation--report from the Italian Registry. Italian Association of Pediatric Hematology-Oncology BMT Group.
    Garaventa A; Rondelli R; Castagnola E; Locatelli F; Dallorso S; Porta F; Uderzo C; Rossetti F; Miniero R; Andolina M
    Bone Marrow Transplant; 1995 Nov; 16(5):669-74. PubMed ID: 8547864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
    Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
    Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
    Brinkman K; Debast S; Sauerwein R; Ooyman F; Hiel J; Raemaekers J
    Bone Marrow Transplant; 1998 Mar; 21(6):635-6. PubMed ID: 9543070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of infections in bone marrow transplant recipients.
    Serody JS; Shea TC
    Infect Dis Clin North Am; 1997 Jun; 11(2):459-77. PubMed ID: 9187956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
    Liem GS; Cornelissen JJ; Oudshoorn M; Sintnicolaas K; Löwenberg B; Hagenbeek A
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1553-6. PubMed ID: 9543748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bartonella-related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft-versus-host disease.
    Vassallo C; Ardigò M; Brazzelli V; Zecca M; Locatelli F; Alessandrino PE; Lazzarino M; Corona S; Lanzerini P; Benazzo M; Fabbi M; Borroni G
    Br J Dermatol; 2007 Jul; 157(1):174-8. PubMed ID: 17553040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infectious complications during autotransplantation.
    Reed EC
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):717-35. PubMed ID: 8344887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of bacterial and fungal infections in bone marrow transplant recipients and other granulocytopenic patients.
    Heidt PJ
    Cancer Detect Prev; 1988; 12(1-6):609-19. PubMed ID: 3052842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infections among allogeneic bone marrow transplant recipients in India.
    George B; Mathews V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2004 Feb; 33(3):311-5. PubMed ID: 14647246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infections in bone marrow transplant recipients in south India--a post-mortem study.
    Ramani P; Krishnaswami H; Srivastava A; Dennison D; Chandy M
    J Trop Med Hyg; 1994 Dec; 97(6):354-6. PubMed ID: 7966537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
    Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H
    Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiologic consequences of new approaches to managing hematologic malignancies.
    Blijlevens NM; Donnelly JP; de Pauw BE
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reducing infectious complications after allogeneic stem cell transplant.
    Bacigalupo A; Metafuni E; Amato V; Marquez Algaba E; Pagano L
    Expert Rev Hematol; 2020 Nov; 13(11):1235-1251. PubMed ID: 32996342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.